From Cancer Cells in Cerebrospinal Fluid and Meninges to Medulloblastoma Cells: Primary Tumors and Metastatic Cancers of the Central Nervous System

被引:1
|
作者
Zhao, Ying [1 ]
Ding, Sheng-Le [2 ]
机构
[1] Lanzhou Univ, Hosp 1, Dept Lab, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Hosp 1, Dept Orthoped, Lanzhou 730000, Peoples R China
关键词
Cerebrospinal Fluid Cytology; Medulloblastoma; Primary Tumors; Central Nervous System; Secondary Tumors; SUBARACHNOID HEMORRHAGE; DIAGNOSIS; BRAIN; CSF;
D O I
10.1166/jbt.2019.2117
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Objective: This study aims to explore the diagnostic methods for tumors of the central nervous system (CNS) based on different morphological characteristics of cerebrospinal fluid (CSF) cells. Methods: Through the case analysis of meningeal carcinoma, medulloblastoma and glioma, combined with computed tomography (CT) and magnetic resonance imaging (MRI), as well as carcinoembryonic antigen (CEA) staining and other staining methods, the morphological characteristics of CSF cells in different tumors of the central nervous were found. Results: Through CT and CEA staining, it was found that the detection rate of primary tumors except for medulloblastoma was generally low (15%-30%), while that of secondary tumors was relatively higher, reaching up to 30%-75%. Measurement data were expressed as mean +/- standard deviation (x +/- SD). Intergroup comparison was conducted using t-test. P < 0.05 was considered statistically significant. Conclusion: In addition to the major morphological features of primary and secondary tumors, in the process of diagnosis, physicians should be aware that the pia matter is a very thin layer of connective tissue, its density is close to the surrounding tissues, and it is very difficult for CT and MRI to distinguish between the pia mater and lesions in it. The determination on whether tumor cells can be detected via CSF cytology depends on whether the tumor invades the subarachnoid space and pia mater. This requires a high degree of responsibility in the diagnosis. Furthermore, the previous examination results should be in contrast, suspected meningeal cancer patients should undergo repeated examinations, and more smears should be made in one examination, in order to improve the positive rate.
引用
收藏
页码:1179 / 1184
页数:6
相关论文
共 50 条
  • [31] CIRCULATING MICRORNAS IN PLASMA AND CEREBROSPINAL FLUID OF PEDIATRIC PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS
    Lulla, Rishi R.
    Costa, Fabricio F.
    Hamm, Christopher A.
    Fangsuaro, Jason
    Sredni, Simone T.
    Vanin, Elio F.
    Goldman, Stewart
    Soares, M. Bento
    NEURO-ONCOLOGY, 2011, 13 : I29 - I29
  • [32] CEREBROSPINAL-FLUID LYSOZYME ACTIVITY IN PATIENTS WITH CENTRAL NERVOUS-SYSTEM TUMORS
    DILORENZO, N
    PALMA, L
    FERRANTE, L
    NEUROCHIRURGIA, 1977, 20 (01) : 19 - 22
  • [33] Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children
    Mikecin, Lili
    Krizmaric, Miljenko
    Giljevic, Jasminka Stepan
    Gjurasin, Miroslav
    Kern, Josipa
    Krleza, Jasna Lenicek
    Popovic, Ljiljana
    CROATIAN MEDICAL JOURNAL, 2013, 54 (05) : 429 - 435
  • [34] SEQ-ING THE SINES OF CENTRAL NERVOUS SYSTEM TUMORS IN CEREBROSPINAL FLUID DNA
    Douville, Christopher
    Bettegowda, Chetan
    NEURO-ONCOLOGY, 2023, 25
  • [35] ASSESSING CEREBROSPINAL FLUID FLOW DYNAMICS IN PEDIATRIC PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS
    Kramer, Kim
    Donzellie, Maria
    Nwora, Emmanuela
    Pandit-Taskar, Neeta
    NEURO-ONCOLOGY, 2019, 21 : 279 - 279
  • [36] Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors
    Buesker, Soeren
    Jaeger, Walter
    Poschner, Stefan
    Mayr, Lisa
    Al Jalali, Valentin
    Gojo, Johannes
    Azizi, Amedeo A.
    Ullah, Sami
    Bilal, Muhammad
    El Tabei, Lobna
    Fuhr, Uwe
    Peyrl, Andreas
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (05) : 617 - 627
  • [37] RELATIONSHIP OF POLYAMINES IN CEREBROSPINAL-FLUID TO PRESENCE OF CENTRAL NERVOUS-SYSTEM TUMORS
    MARTON, LJ
    HEBY, O
    LEVIN, VA
    LUBICH, WP
    CRAFTS, DC
    WILSON, CB
    CANCER RESEARCH, 1976, 36 (03) : 973 - 977
  • [38] CYTOMORPHOLOGY OF THE CEREBROSPINAL-FLUID .1. TUMORS OF THE CENTRAL NERVOUS-SYSTEM
    CASTRO, A
    CASTILLO, J
    LEMA, M
    CORTES, JA
    AMIGO, MC
    NOYA, M
    MEDICINA CLINICA, 1980, 75 (07): : 301 - 305
  • [39] Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors
    Sören Büsker
    Walter Jäger
    Stefan Poschner
    Lisa Mayr
    Valentin Al Jalali
    Johannes Gojo
    Amedeo A. Azizi
    Sami Ullah
    Muhammad Bilal
    Lobna El Tabei
    Uwe Fuhr
    Andreas Peyrl
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 617 - 627
  • [40] CEREBROSPINAL-FLUID BIOCHEMICAL MARKERS IN CENTRAL NERVOUS-SYSTEM TUMORS - A REVIEW
    WASSERSTROM, WR
    SCHWARTZ, MK
    FLEISHER, M
    POSNER, JB
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1981, 11 (03): : 239 - 251